Beijing Beilu Pharmaceutical Co., Ltd reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 188.04 million compared to CNY 183.93 million a year ago. Revenue was CNY 188.04 million compared to CNY 183.93 million a year ago.

Net income was CNY 12.58 million compared to CNY 39.26 million a year ago. Basic earnings per share from continuing operations was CNY 0.0256 compared to CNY 0.08 a year ago.